BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 35669857)

  • 1. The Massachusetts public health data warehouse and the opioid epidemic: A qualitative study of perceived strengths and limitations for advancing research.
    Evans EA; Delorme E; Cyr KD; Geissler KH
    Prev Med Rep; 2022 Aug; 28():101847. PubMed ID: 35669857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A qualitative study of big data and the opioid epidemic: recommendations for data governance.
    Evans EA; Delorme E; Cyr K; Goldstein DM
    BMC Med Ethics; 2020 Oct; 21(1):101. PubMed ID: 33087123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Big Data and Ethical Issues for Populations With Substance Use Disorder.
    Evans EA; Geissler KH
    Value Health; 2023 Sep; 26(9):1321-1324. PubMed ID: 36921899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The opioid epidemic in rural northern New England: An approach to epidemiologic, policy, and legal surveillance.
    Stopka TJ; Jacque E; Kelso P; Guhn-Knight H; Nolte K; Hoskinson R; Jones A; Harding J; Drew A; VanDonsel A; Friedmann PD
    Prev Med; 2019 Nov; 128():105740. PubMed ID: 31158400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Rapid Review of the Impact of Systems-Level Policies and Interventions on Population-Level Outcomes Related to the Opioid Epidemic, United States and Canada, 2014-2018.
    Ansari B; Tote KM; Rosenberg ES; Martin EG
    Public Health Rep; 2020; 135(1_suppl):100S-127S. PubMed ID: 32735190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massachusetts dental public health program directors practice behaviors and perceptions of infection control.
    November-Rider D; Bray KK; Eklund KJ; Williams KB; Mitchell TV
    J Dent Hyg; 2012; 86(3):248-55. PubMed ID: 22947848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "The gatekeepers in prevention": Community pharmacist perceptions of their role in the opioid epidemic.
    Vadiei N; Eldridge LA; Meyerson BE; Agley J
    Subst Abus; 2022; 43(1):319-327. PubMed ID: 34214407
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014.
    Burke LG; Zhou X; Boyle KL; Orav EJ; Bernson D; Hood ME; Land T; Bharel M; Frakt AB
    Addiction; 2020 Mar; 115(3):493-504. PubMed ID: 31691390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
    Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
    Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.
    Stopka TJ; Donahue A; Hutcheson M; Green TC
    J Am Pharm Assoc (2003); 2017; 57(2S):S34-S44. PubMed ID: 28189540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community Opioid Dispensing After Injury (CODI): Protocol for a Population-Based Data Linkage Study.
    Cameron CM; McCreanor V; Shibl R; Smyth T; Proper M; Warren J; Vallmuur K; Bradford N; Carter H; Graves N; Loveday B
    JMIR Res Protoc; 2022 Apr; 11(4):e36357. PubMed ID: 35412468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing pharmacists' readiness to dispense naloxone and counsel on responding to opioid overdoses.
    Melaragni F; Levy C; Pedrazzi J; Andersen M
    J Am Pharm Assoc (2003); 2019; 59(4):550-554.e2. PubMed ID: 31109812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist Views Regarding the Prescription Opioid Epidemic.
    Rao D; Giannetti V; Kamal KM; Covvey JR; Tomko JR
    Subst Use Misuse; 2021; 56(14):2096-2105. PubMed ID: 34429024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post opioid overdose outreach by public health and public safety agencies: Exploration of emerging programs in Massachusetts.
    Formica SW; Apsler R; Wilkins L; Ruiz S; Reilly B; Walley AY
    Int J Drug Policy; 2018 Apr; 54():43-50. PubMed ID: 29414484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "People need them or else they're going to take fentanyl and die": A qualitative study examining the 'problem' of prescription opioid diversion during an overdose epidemic.
    Bardwell G; Small W; Lavalley J; McNeil R; Kerr T
    Soc Sci Med; 2021 Jun; 279():113986. PubMed ID: 33971445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating Public Health and Health Care Strategies to Address the Opioid Epidemic: The Oregon Health Authority's Opioid Initiative.
    Hedberg K; Bui LT; Livingston C; Shields LM; Van Otterloo J
    J Public Health Manag Pract; 2019; 25(3):214-220. PubMed ID: 30048336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.